Skip to main content

and
  1. No Access

    Article

    Fludarabine phosphate for the treatment of low grade lymphoid malignancy

    Thirty-four patients with previously treated, advanced, low grade NHL were treated with Fludarabine, a deamination-resistant analogue of adenosine arabinoside, at a dose of 25 mg m-2 intravenously, daily for 5...

    JS Whelan, CL Davis, S Rule, M Ranson, OP Smith, AB Mehta in British Journal of Cancer (1991)

  2. No Access

    Article

    The EBMT/EMCL consensus project on the role of autologous and allogeneic stem cell transplantation in mantle cell lymphoma

    The role of both autologous (autoSCT) and allogeneic stem cell transplantation (alloSCT) in the management of mantle cell lymphoma (MCL) remains to be clarified. We conducted a consensus project using the RAND...

    S Robinson, P Dreger, D Caballero, P Corradini, C Geisler, M Ghielmini in Leukemia (2015)

  3. Article

    Open Access

    Ibrutinib versus temsirolimus: 3-year follow-up of patients with previously treated mantle cell lymphoma from the phase 3, international, randomized, open-label RAY study

    S Rule, W Jurczak, M Jerkeman, C Rusconi, M Trneny, F Offner, D Caballero in Leukemia (2018)

  4. Article

    Open Access

    Updated results from the phase 3 HELIOS study of ibrutinib, bendamustine, and rituximab in relapsed chronic lymphocytic leukemia/small lymphocytic lymphoma

    We report follow-up results from the randomized, placebo-controlled, phase 3 HELIOS trial of ibrutinib+bendamustine and rituximab (BR) for previously treated chronic lymphocytic leukemia (CLL)/small lymphocyti...

    G. Fraser, P. Cramer, F. Demirkan, R. Santucci Silva, S. Grosicki, A. Pristupa in Leukemia (2019)